Thinking outside the box-The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect

This study provides evidence that subsetting using antibody markers in addition to extent of skin involvement may predict clinical outcomes better than skin or serology alone in SSc. These findings can inform ongoing efforts to define more robust SSc subsets compared to those based on the extent of skin involvement or serology alone.